10.1002/ejoc.201800346
European Journal of Organic Chemistry
FULL PAPER
N, 12.65; ee > 99 %, CSP-A column, hexane-EtOH, 6 : 4, 1 mL/min, 254
nm, rt, tR(S) = 4.7 min., tR(R) = 5.6 min, [α]D25 – 21.2 (c 1.0, THF).
8.92 (2H, d, J = 1.9 Hz, DNBAr), 6.88 (2H, s, Ar), 6.82, (1H, br s, NH),
6.30–6.24 (1H, m, CHNH), 6.16 (1H, ddd, J = 17.2, 10.4, 3.8 Hz, CH=CH2),
5.30 (1H, d, J = 10.4 Hz, CH2=CH), 5.13 (1H, d, J = 17.2 Hz, CH2=CH),
2.45 (6H, s, ArCH3), 2.26 (3H, s, ArCH3); 13C NMR (75 MHz, CDCl3) δ
161.88, 148.70, 137.84, 137.69, 136.34, 136.31, 132.43, 130.32, 127.03,
121.09, 116.34, 52.49, 20.93, 20.76; C19H19N3O5 requires: C, 61.78; H,
5.18; N, 11.38, found: C, 61.39; H, 5.48; N, 10.91
(S)-N-(1-(2,4,6-trimethylphenyl)allyl)-3,5-dinitrobenzamide was prepared
using semi-preparative chiral HPLC chromatography CSP-A column,
hexane-DCM-MeOH, 65 : 35 : 1.5, 5 mL/min, 254 nm, rt. Racemic amide
(100 mg) was dissolved in DCM- hexane, 2 : 3 (12 mL) and 0.3 – 0.4 mL
was injected. Approximately 34 runs were performed to resolve 100 mg of
(S)-N-(1-(4-methylphenyl)allyl)-3,5-dinitrobenzamide
(S-DNB-2):
White solid (1.19, 92%) starting from (S)-1-(4-methylphenyl)-prop-2-en-1-
amine (0.56 g). Purified by recrystallization from methanol. mp 191.9–
192.8 °C; νmax/cm-1 3317, 1639, 1543, 1342, 1077, 921, 730, 722; 1H NMR
(300 MHz, CDCl3) δ 9.14 (1H, t, J = 2.0 Hz, DNBAr), 8.97 (2H, d, J = 2.0
Hz, DNBAr), 7.25 (2H, d, J = 8.1 Hz, Ar), 7.17 (2H, d, J = 8.1 Hz, Ar), 6.95
(1H, br s, NH), 6.14 (1H, ddd, J = 17.1, 10.4, 5.5 Hz, CH=CH2), 5.79 (1H,
m, CHNH), 5.37 (1H, d, J = 10.4 Hz, CH2=CH), 5.31 (1H, d, J = 17.1 Hz,
CH2=CH), 2.34 (3H, s, ArCH3); 13C NMR (75 MHz, CDCl3) δ 161.76,
148.66, 138.21, 137.75, 136.36, 136.27, 129.74, 127.30, 127.20, 121.17,
116.95, 56.29, 21.11; C17H15N3O5 requires: C, 59.82; H, 4.43; N, 12.31,
amide. mp 66.2–67.5 °C; ee > 99 %, CSP-A column, hexane-DCM-MeOH,
25
65 : 35 : 1.5, 1 mL/min, 254 nm, rt, tR(S) = 7.4 min., tR(R) = 8.3 min, [α]D
78.4 (c 1.2, DCM)
-
found: C, 59.44; H, 4.49; N, 12.28; ee > 99 %, CSP-A column, hexane-2-
25
propanol, 1:1, 1 mL/min, 254 nm, rt, tR(S) = 6.7 min, tR(R) = 8.7 min, [α]D
24,2 (c 1.0, DCM).
-
(S)-N-(1-Naphthalen-1-yl-allyl)-3,5-dinitrobenzamide (S-DNB-6): White
solid (1.21 g, 90 %) starting from (S)-1-(1-naphthalenyl)-prop-2-en-1-
amine (0.65 g). Purified by recrystallization from methanol with 1 %
acetone. mp 210.1–211.7 °C; νmax/cm-1 3280, 1644, 1545, 1344, 1074, 922,
805, 782, 731, 717; 1H NMR (300 MHz, CDCl3) δ 9.09 (1H, t, J = 2.2 Hz,
DNBAr), 8.91 (2H, d, J = 2.2 Hz, DNBAr), 8.01 (1H, m, Ar), 7.88–7.83 (2H,
m, Ar), 7.56–7.43 (4H, m, Ar), 6.92 (1H, br s, NH), 6.55 (1H, m, CHNH),
6.26 (1H, ddd, J = 17.1, 10.5, 4.6 Hz, CH=CH2), 5.45 (1H, d, J = 10.5 Hz,
CH2=CH), 5.34 (1H, d, J = 17.1 Hz, CH2=CH); 13C NMR (75 MHz, CDCl3)
δ 161.28, 147.97, 136.68, 135.38, 134.39, 133.47, 130.51, 128.78, 128.46,
126.68, 126.61, 125.79, 124.75, 124.70, 122.48, 120.64, 116.35, 51.77;
C20H15N3O5 requires: C, 63.66; H, 4.01; N, 11.14; found: C, 63.40; H, 3.98;
(S)-N-(1-(3,5-dimethylphenyl)allyl)-3,5-dinitrobenzamide (S-DNB-3):
White solid (0.20, 86%) starting from 1-(3,5-dimethylphenyl)-prop-2-en-1-
amine (0.10 g). Purified by recrystallization from methanol. mp 202.7–
204.2 °C; νmax/cm-1 3313, 1649, 1543, 1345, 1080, 917, 849, 729, 698; 1H
NMR (300 MHz, CDCl3) δ 9.16 (1H, t, J = 2.1 Hz, DNBAr), 8.95 (2H, d, J
= 2.1 Hz, DNBAr), 6.98 (3H, s, Ar), 6.56 (1H, br s, NH), 6.12 (1H, ddd, J =
17.0, 10.3, 5.5 Hz, CH=CH2), 5.77 (1H, m, CHNH), 5.36 (1H, d, J = 10.3
Hz, CH2=CH), 5.31 (1H, d, J = 17.0 Hz, CH2=CH), 2.33 (6H, s, ArCH3); 13
C
NMR (75 MHz, CDCl3) δ 161.68, 148.70, 139.27, 138.82, 137.82, 136.36,
130.02, 127.17, 125.15, 121.13, 116.70, 56.52, 21.30; C18H17N3O5
requires: C, 60.84; H, 4.82; N, 11.83, found: C, 61.14; H, 5.08; N, 11.53
(S)-N-(1-(3,5-dimethylphenyl)allyl)-3,5-dinitrobenzamide was prepared
using semi-preparative chiral HPLC chromatography, CSP-A column,
hexane-DCM-MeOH, 50 : 100 : 1, 5 mL/min, 254 nm, rt. Racemic amide
(100 mg) was dissolved in DCM-hexane, 4 : 1 (20 mL) and 0.8 – 0.9 mL
was injected. Approximately 23 runs were performed to resolve 100 mg of
amide. mp 175.0–175.6 °C; ee > 99 %, CSP-A column, hexane-DCM-
methanol, 50:100:1, 1 mL/min, 254 nm, rt, tR(S) = 8.6 min, tR(R) = 11.3 min,
[α]D25 -33.7 (c 0.9, DCM).
N, 10.85; ee > 99 %, CSP-A column, MeOH, 1 mL/min, 254 nm, rt, tR(S)
3.7 min, tR(R) = 4.5 min, [α]D25 -14.3 (c 1.0, DCM).
=
(S)-N-(1-(4-methylnaphthalen-1-yl)allyl)-3,5-dinitrobenzamide
(S-
DNB-7): Light yellow solid (0.34 g, 78%) starting from (S)-1-(4-
methylnaphthalen-1-yl)-prop-2-en-1-amine (0.22 g). Purified by
recrystallization from MeOH with 1 % DCM. mp 186.0–186.7 °C; νmax/cm-
1 3340, 1642, 1543, 1524, 1343, 921, 766, 732, 721; 1H NMR (300 MHz,
DMSO) δ 9.77 (1H, d, J = 7.9 Hz, NH), 9.14 (2H, d, J = 1.9 Hz, DNBAr),
8.93 (1H, t, J = 1.9 Hz, DNBAr), 8.17–8.13 (1H, m, Ar), 8.09–8.04 (1H, m,
Ar), 7.61–7.55 (2H, m, Ar), 7.50 (1H, d, J = 7.2 Hz, Ar), 7.40 (1H, d, J = 7.2
Hz, Ar), 6.52 (1H, m, CHNH), 6.31 (1H, ddd, J = 17.0, 10.4, 5.4 Hz,
CH=CH2), 5.34 (1H, d, J = 10.4 Hz, CH2=CH), 5.31 (1H, d, J = 17.0 Hz,
CH2=CH), 2.65 (3H, s, ArCH3); 13C NMR (75 MHz, DMSO) δ 161.34,
148.15, 137.25, 136.42, 134.33, 134.09, 132.41, 130.87, 127.79, 126.19,
125.97, 125.72, 124.86, 124.77, 123.65, 120.96, 116.24, 51.71, 19.13;
C21H17N3O5 requires: C, 64.45; H, 4.38; N, 10.74, found: C, 63.67; H, 4.65;
(S)-N-(1-(2-methylphenyl)allyl)-3,5-dinitrobenzamide
(S-DNB-4):
White solid (0.70 g, 97 %) starting from 1-(2-methylphenyl)-prop-2-en-1-
amine (0.31 g). Purified by column chromatography in DCM-MeOH, 100 :
1 (Rf = 0.63). mp 160.2–161.5 °C; νmax/cm-1 3289, 1641, 1540, 1344, 1078,
920, 731, 720; 1H NMR (300 MHz, CDCl3) δ 9.15 (1H, t, J = 2.0 Hz, DNBAr),
8.95 (2H, d, J = 2.0 Hz, DNBAr), 7.33–7.28 (1H, m, Ar), 7.25–7.20 (3H, m,
Ar), 6.68 (1H, br s, NH), 6.14 (1H, ddd, J = 16.9, 10.2, 4.9 Hz, CH=CH2),
6.03 (1H, m, CHNH), 5.37 (1H, d, J = 10.2 Hz, CH2=CH), 5.25 (1H, d, J =
16.9 Hz, CH2=CH), 2.41 (3H, s, ArCH3); 13C NMR (75 MHz, CDCl3) δ
161.71, 148.68, 137.55, 137.27, 136.53, 136.02, 131.08, 128.31, 127.17,
126.65, 126.53, 121.20, 116.74, 53.09, 19.23; C17H15N3O5 requires: C,
59.82; H, 4.43; N, 12.31, found: C, 59.63; H, 4.29; N, 11.99
(S)-N-(1-(2-methylphenyl)allyl)-3,5-dinitrobenzamide was prepared using
semi-preparative chiral HPLC chromatography, CSP-A column, hexane-
DCM-MeOH, 40 : 60 : 1, 5 mL/min, 254 nm, rt. Racemic amide (100 mg)
was dissolved in DCM-hexane, 4 : 1 (15 mL) and 0.7 mL was injected.
Approximately 21 runs were performed to resolve 100 mg of amide. mp
202.3–203.2 °C; ee > 99 %, CSP-A column, hexane-DCM-methanol,
40:60:1, 1 mL/min, 254 nm, rt, tR(S) = 6.3 min, tR(R) = 7.8 min, [α]D25 -23.5
(c 1.0, DCM)
N, 10.54; ee > 99 %, CSP-A column, MeOH, 1 mL/min, 254 nm, rt, tR(S)
4.2 min, tR(R) = 5.5 min, [α]D25 -21.8 (c 1.2, DCM).
=
(S)-N-(1-(2-methylnaphthalen-1-yl)allyl)-3,5-dinitrobenzamide
(S-
DNB-8): Yellow solid (1.04 g, 88%) starting from 1-(2-methylnaphthalen-
1-yl)-prop-2-en-1-amine (0.59 g). Purified by recrystallization from
methanol with 5 % DCM. mp 233.4–234.2 °C; νmax/cm-1 3321, 1638, 1543,
1347, 1074, 819, 730, 718; 1H NMR (300 MHz, DMSO) δ 9.90 (1H, d, J =
5.4 Hz, NH), 9.06 (2H, d, J = 2.0 Hz, DNBAr), 8.91 (1H, t, J = 2.0 Hz,
DNBAr), 8.37 (1H, d, J = 8.4 Hz, Ar), 7.86 (1H, d, J = 7.6 Hz, Ar), 7.76 (1H,
d, J = 8.4 Hz, Ar), 7.52–7.40 (2H, m, Ar), 7.36 (1H, d, J = 8.4 Hz, Ar), 6.50
(1H, ddd, J = 17.0, 10.4, 4.9 Hz, CH=CH2), 6.41 (1H, m, CHNH), 5.25 (1H,
d, J = 10.4 Hz, CH2=CH), 5.04 (1H, d, J = 17.0 Hz, CH2=CH), 2.68 (3H, s,
ArCH3); 13C NMR (75 MHz, DMSO) δ 161.93, 148.04, 137.03, 136.55,
134.74, 133.09, 132.82, 130.67, 129.48, 128.65, 127.83, 127.80, 125.55,
125.11, 124.47, 120.85, 116.50, 53.07, 20.78; C21H17N3O5 requires: C,
64.45; H, 4.38; N, 10.74, found: C, 63.80; H, 4.49; N, 10.47
(S)-N-(1-(2,4,6-trimethylphenyl)allyl)-3,5-dinitrobenzamide (S-DNB-5):
White solid (0.66 g, 91%) starting from 1-(2,4,6-trimethylphenyl)-prop-2-
en-1-amine (0.34 g). Purified by column chromatography in DCM (Rf =
0.42). mp 186.3–187.8 °C; νmax/cm-1 3362, 1643, 1541, 1346, 1076, 919,
(S)-N-(1-(2-methylnaphthalen-1-yl)allyl)-3,5-dinitrobenzamide
was
1
prepared using semi-preparative chiral HPLC chromatography, CSP-A
731, 719; H NMR (300 MHz, CDCl3) δ 9.15 (1H, t, J = 1.9 Hz, DNBAr),
This article is protected by copyright. All rights reserved.